The spatial genomics & transcriptomics market is expected to grow from USD 0.67 billion in 2026 to USD 1.23 billion in 2031, at a CAGR of 12.9% during the forecast period. The market is expected to grow steadily, driven by increasing use of spatial profiling in oncology research, precision medicine, drug discovery, biomarker identification, and translational studies. Technologies such as spatial transcriptomics, in situ hybridization, sequencing-based spatial analysis, and high-plex molecular imaging enable the investigation of gene expression, cellular interactions, tissue architecture, and disease mechanisms. These tools support applications across cancer research, therapeutic target identification, treatment-response assessment, neuroscience, immunology, and developmental biology. Growing interest in single-cell analysis, multi-omics integration, and AI-enabled spatial data interpretation is further strengthening adoption across pharmaceutical, biotechnology, academic, clinical research, and CRO settings. In addition, demand for high-resolution instruments, reliable assay kits, validated probes, sequencing reagents, automated sample preparation, and bioinformatics solutions is improving workflow efficiency and data quality.
The report’s scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the spatial genomics & transcriptomics market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product & service portfolio, key strategies, new product/service launches, acquisitions, and recent developments related to the market. This report also includes a competitive analysis of emerging startups in the spatial genomics & transcriptomics ecosystem.
Spatial genomics segment to grow at the highest CAGR in the spatial genomics & transcriptomics products market from 2026 to 2031
By technique, the spatial genomics segment is expected to grow at the highest CAGR during the forecast period, driven by increasing demand for high-resolution analysis of gene expression within intact tissues. Growing applications in oncology, biomarker discovery, drug development, and precision medicine are increasing the need for specialized services that integrate spatial profiling with advanced data analysis. These services help researchers characterize cellular interactions, tissue architecture, and disease-associated molecular patterns, supporting deeper biological insights across pharmaceutical, biotechnology, and academic research settings.Sequencing & analytical services segment to hold the largest share of the spatial genomics & transcriptomics services market in 2025
By type, the sequencing & analytical services segment is likely to account for the largest share of the services market in 2025, driven by the growing need to process and interpret complex spatial molecular data. These services enable researchers to analyze gene expression patterns, identify cellular interactions, and characterize tissue heterogeneity. Increasing applications in oncology, biomarker discovery, drug development, and translational research continue to support demand across pharmaceutical companies, biotechnology firms, and academic research institutes.North America to register the second-highest CAGR in the spatial genomics & transcriptomics market between 2026 and 2031
By region, North America is expected to experience strong market growth during the forecast period, supported by substantial investments in precision medicine, advanced biomedical research infrastructure, and increasing adoption of spatial profiling technologies. Leading companies, including 10x Genomics (US), Illumina, Inc. (US), and Bruker (US), support regional growth through product innovation and platform development. Rising applications in oncology, neuroscience, biomarker discovery, and drug development, alongside pharmaceutical R&D investments and research collaborations, are expected to accelerate technology adoption across the region.The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side - 70% and Demand Side- 30%
- By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe - 25%, Asia Pacific - 25%, Latin America - 5%, and the Middle East & Africa - 5%
Research Coverage
This research report categorizes the spatial genomics & transcriptomics market by offering (products and services), products market by technique (spatial transcriptomics and spatial genomics), services market by type (sample preparation services, sequencing & analytical services, and data visualization & analysis services), application (translational research and drug discovery & development), products market by end user (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and clinical diagnostic laboratories), services market by end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).The report’s scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the spatial genomics & transcriptomics market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product & service portfolio, key strategies, new product/service launches, acquisitions, and recent developments related to the market. This report also includes a competitive analysis of emerging startups in the spatial genomics & transcriptomics ecosystem.
Key Benefits of Buying the Report
The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market’s pulse and offer information on key market drivers, restraints, opportunities, and challenges.The report provides insights into the following pointers:
- Market Dynamics: Analysis of key drivers (Increasing adoption of spatial genomics and transcriptomics in drug discovery and development, Introduction of novel spatial genomics and transcriptomics products, Increasing pharmaceutical R&D investments and public-private funding), restraints (High initial capital investments and maintenance costs, High data complexity and computational requirements), opportunities (Increasing use of spatial omics for biomarker identification, Increasing demand for precision medicines and targeted drug development), and challenges (Lack of standardization and reproducibility across spatial technologies ) influencing the spatial genomics & transcriptomics market growth
- Product Development/Innovation: Detailed insights into newly launched products and innovations in the market
- Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products & services of leading players, such as 10x Genomics (US), Bio- Techne (US), Bruker (US), Standard BioTools Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Visiopharm A/S (Denmark), and Danaher Corporation (US), among others, in the market
Table of Contents
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.3.5 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.3.5 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW
3.2 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
3.3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION,2026 VS. 2031 (%)
3.2 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
3.3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION,2026 VS. 2031 (%)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery and development
4.2.1.2 Introduction of novel spatial genomics & transcriptomics products
4.2.1.3 Increasing pharmaceutical R&D investments and public-private funding
4.2.2 RESTRAINTS
4.2.2.1 High initial capital investments and maintenance costs
4.2.2.2 High data complexity and computational requirements
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing use of spatial omics for biomarker identification
4.2.3.2 Increasing demand for precision medicines and targeted drug development
4.2.4 CHALLENGES
4.2.4.1 Lack of standardization and reproducibility across spatial technologies
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery and development
4.2.1.2 Introduction of novel spatial genomics & transcriptomics products
4.2.1.3 Increasing pharmaceutical R&D investments and public-private funding
4.2.2 RESTRAINTS
4.2.2.1 High initial capital investments and maintenance costs
4.2.2.2 High data complexity and computational requirements
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing use of spatial omics for biomarker identification
4.2.3.2 Increasing demand for precision medicines and targeted drug development
4.2.4 CHALLENGES
4.2.4.1 Lack of standardization and reproducibility across spatial technologies
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 THREAT FROM SUBSTITUTES
5.1.5 THREAT FROM NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
5.5.1.1 Instruments
5.5.1.2 Consumables
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT SCENARIO (HS CODE 9027)
5.6.2 EXPORT SCENARIO (HS CODE 9027)
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS CHARACTERIZESTHE TUMOR MICROENVIRONMENT
5.10.2 COSMX WHOLE-TRANSCRIPTOME IMAGING REVEALS MOLECULAR HETEROGENEITY IN KIDNEY CANCER
5.10.3 INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS REVEAL GENOME ORGANIZATION IN BREAST CANCER
5.11 IMPACT OF 2025 US TARIFFS - SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRIES/REGIONS
5.11.4.1 US
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Pharmaceutical & biotechnology companies
5.11.5.2 Academic & research institutes
5.11.5.3 CROs & CDMOs
5.11.5.4 Clinical diagnostic laboratories
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 THREAT FROM SUBSTITUTES
5.1.5 THREAT FROM NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
5.5.1.1 Instruments
5.5.1.2 Consumables
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT SCENARIO (HS CODE 9027)
5.6.2 EXPORT SCENARIO (HS CODE 9027)
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS CHARACTERIZESTHE TUMOR MICROENVIRONMENT
5.10.2 COSMX WHOLE-TRANSCRIPTOME IMAGING REVEALS MOLECULAR HETEROGENEITY IN KIDNEY CANCER
5.10.3 INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS REVEAL GENOME ORGANIZATION IN BREAST CANCER
5.11 IMPACT OF 2025 US TARIFFS - SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRIES/REGIONS
5.11.4.1 US
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Pharmaceutical & biotechnology companies
5.11.5.2 Academic & research institutes
5.11.5.3 CROs & CDMOs
5.11.5.4 Clinical diagnostic laboratories
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY TECHNOLOGIES
6.1.1.1 In situ sequencing
6.1.1.2 In situ hybridization
6.1.1.3 Spatial barcoding and sequencing
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Tissue imaging and histopathological analysis
6.1.2.2 Spatial heatmap
6.1.2.3 Differential gene expression analysis
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Multi-omics
6.1.3.2 Metabolomics
6.1.3.3 Single-cell analysis
6.2 TECHNOLOGY ROADMAP
6.3 PATENT ANALYSIS
6.3.1 METHODOLOGY
6.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
6.3.3 LIST OF KEY PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
6.5.1 TOP USE CASES AND MARKET POTENTIAL
6.5.2 BEST PRACTICES IN AI-ENABLED SPATIAL GENOMICS & TRANSCRIPTOMICS WORKFLOWS
6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
6.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES
6.1.1 KEY TECHNOLOGIES
6.1.1.1 In situ sequencing
6.1.1.2 In situ hybridization
6.1.1.3 Spatial barcoding and sequencing
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Tissue imaging and histopathological analysis
6.1.2.2 Spatial heatmap
6.1.2.3 Differential gene expression analysis
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Multi-omics
6.1.3.2 Metabolomics
6.1.3.3 Single-cell analysis
6.2 TECHNOLOGY ROADMAP
6.3 PATENT ANALYSIS
6.3.1 METHODOLOGY
6.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
6.3.3 LIST OF KEY PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
6.5.1 TOP USE CASES AND MARKET POTENTIAL
6.5.2 BEST PRACTICES IN AI-ENABLED SPATIAL GENOMICS & TRANSCRIPTOMICS WORKFLOWS
6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
6.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER (PRODUCT)
8.2.3 KEY BUYING CRITERIA, BY END USER (SERVICES)
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA, BY END USER (PRODUCT)
8.2.3 KEY BUYING CRITERIA, BY END USER (SERVICES)
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
9.1 INTRODUCTION
9.2 PRODUCTS
9.2.1 INSTRUMENTS & SOFTWARE
9.2.1.1 Instruments & software to facilitate disease research by enabling detailed spatial mapping and multi-omic analyses
9.2.2 CONSUMABLES
9.2.2.1 Better reproducible and high-quality data collection to advance spatial genomics research in oncology and precision medicine
9.3 SERVICES
9.3.1 INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH
9.2 PRODUCTS
9.2.1 INSTRUMENTS & SOFTWARE
9.2.1.1 Instruments & software to facilitate disease research by enabling detailed spatial mapping and multi-omic analyses
9.2.2 CONSUMABLES
9.2.2.1 Better reproducible and high-quality data collection to advance spatial genomics research in oncology and precision medicine
9.3 SERVICES
9.3.1 INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH
10 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE
10.1 INTRODUCTION
10.2 SPATIAL TRANSCRIPTOMICS
10.2.1 IMMUNOHISTOCHEMISTRY
10.2.1.1 Increasing applications in biomarker discovery and cellular interactions within tissue architecture to drive segment
10.2.2 RNA SEQUENCING
10.2.2.1 In situ RNA sequencing
10.2.2.1.1 Integration of ISS with bioinformatics toolkits for data analysis to facilitate interpretation of complex datasets
10.2.2.2 Single-cell RNA sequencing
10.2.2.2.1 Increasing commercial availability of scRNA-seq platforms and advancements in bioinformatics tools to drive segment
10.2.2.3 Other RNA sequencing
10.2.3 IN SITU HYBRIDIZATION
10.2.3.1 High-throughput and 3D spatial gene expression analysis in cancer research and developmental biology to drive segment
10.2.4 MICROSCOPY-BASED RNA IMAGING
10.2.4.1 Better insights into molecular communication within tissue architecture to augment segment growth
10.2.5 IMMUNOFLUORESCENCE
10.2.5.1 Advanced profiling of immune-tumor microenvironments for cancer diagnosis and prognosis to propel segment growth
10.2.6 LASER CAPTURE MICRODISSECTION
10.2.6.1 Analysis of gene expression data from defined cellular populations to facilitate spatial mapping within tissue sections
10.2.7 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
10.3 SPATIAL GENOMICS
10.3.1 IN SITU HYBRIDIZATION
10.3.1.1 Demand for high-specificity detection platforms to fuel market growth
10.3.2 LASER CAPTURE MICRODISSECTION
10.3.2.1 Detailed insights into cellular mechanisms and molecular profiles within heterogeneous tissue samples to drive segment
10.3.3 GENOMIC SEQUENCING
10.3.3.1 Microdissection-based sequencing
10.3.3.1.1 Increased demand for precision medicines to boost segment growth
10.3.3.2 Chromatin accessibility sequencing
10.3.3.2.1 Need for insights into gene regulation and epigenetic modifications to aid segment growth
10.3.3.3 Other genomic sequencing
10.3.4 OTHER SPATIAL GENOMICS TECHNIQUES
10.2 SPATIAL TRANSCRIPTOMICS
10.2.1 IMMUNOHISTOCHEMISTRY
10.2.1.1 Increasing applications in biomarker discovery and cellular interactions within tissue architecture to drive segment
10.2.2 RNA SEQUENCING
10.2.2.1 In situ RNA sequencing
10.2.2.1.1 Integration of ISS with bioinformatics toolkits for data analysis to facilitate interpretation of complex datasets
10.2.2.2 Single-cell RNA sequencing
10.2.2.2.1 Increasing commercial availability of scRNA-seq platforms and advancements in bioinformatics tools to drive segment
10.2.2.3 Other RNA sequencing
10.2.3 IN SITU HYBRIDIZATION
10.2.3.1 High-throughput and 3D spatial gene expression analysis in cancer research and developmental biology to drive segment
10.2.4 MICROSCOPY-BASED RNA IMAGING
10.2.4.1 Better insights into molecular communication within tissue architecture to augment segment growth
10.2.5 IMMUNOFLUORESCENCE
10.2.5.1 Advanced profiling of immune-tumor microenvironments for cancer diagnosis and prognosis to propel segment growth
10.2.6 LASER CAPTURE MICRODISSECTION
10.2.6.1 Analysis of gene expression data from defined cellular populations to facilitate spatial mapping within tissue sections
10.2.7 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
10.3 SPATIAL GENOMICS
10.3.1 IN SITU HYBRIDIZATION
10.3.1.1 Demand for high-specificity detection platforms to fuel market growth
10.3.2 LASER CAPTURE MICRODISSECTION
10.3.2.1 Detailed insights into cellular mechanisms and molecular profiles within heterogeneous tissue samples to drive segment
10.3.3 GENOMIC SEQUENCING
10.3.3.1 Microdissection-based sequencing
10.3.3.1.1 Increased demand for precision medicines to boost segment growth
10.3.3.2 Chromatin accessibility sequencing
10.3.3.2.1 Need for insights into gene regulation and epigenetic modifications to aid segment growth
10.3.3.3 Other genomic sequencing
10.3.4 OTHER SPATIAL GENOMICS TECHNIQUES
11 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE
11.1 INTRODUCTION
11.2 SAMPLE PREPARATION SERVICES
11.2.1 NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH
11.3 SEQUENCING & ANALYTICAL SERVICES
11.3.1 SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS
11.4 DATA VISUALIZATION & ANALYSIS SERVICES
11.4.1 INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH
11.2 SAMPLE PREPARATION SERVICES
11.2.1 NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH
11.3 SEQUENCING & ANALYTICAL SERVICES
11.3.1 SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS
11.4 DATA VISUALIZATION & ANALYSIS SERVICES
11.4.1 INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH
12 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 TRANSLATIONAL RESEARCH
12.2.1 CANCER
12.2.1.1 Spatial genomics and transcriptomics to map precise locations of DNA and RNA within tumor tissues in cancer research
12.2.2 IMMUNOLOGY
12.2.2.1 Need for better understanding of immune cell interactions and tissue-specific immune responses to propel segment growth
12.2.3 NEUROSCIENCE
12.2.3.1 Increased focus on mapping cellular diversity for analyzing brain function and dysfunction to aid market growth
12.2.4 INFECTIOUS DISEASES
12.2.4.1 Need for enhanced understanding of pathogen-host interactions at tissue level to drive adoption
12.2.5 OTHER DISEASES
12.3 DRUG DISCOVERY & DEVELOPMENT
12.3.1 RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT AND DRUG DISCOVERY TO DRIVE MARKET
12.2 TRANSLATIONAL RESEARCH
12.2.1 CANCER
12.2.1.1 Spatial genomics and transcriptomics to map precise locations of DNA and RNA within tumor tissues in cancer research
12.2.2 IMMUNOLOGY
12.2.2.1 Need for better understanding of immune cell interactions and tissue-specific immune responses to propel segment growth
12.2.3 NEUROSCIENCE
12.2.3.1 Increased focus on mapping cellular diversity for analyzing brain function and dysfunction to aid market growth
12.2.4 INFECTIOUS DISEASES
12.2.4.1 Need for enhanced understanding of pathogen-host interactions at tissue level to drive adoption
12.2.5 OTHER DISEASES
12.3 DRUG DISCOVERY & DEVELOPMENT
12.3.1 RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT AND DRUG DISCOVERY TO DRIVE MARKET
13 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKETBY END USER
13.1 INTRODUCTION
13.2 ACADEMIC & RESEARCH INSTITUTES
13.2.1 FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH
13.3 CROS & CDMOS
13.3.1 GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH
13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.4.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION
13.5 CLINICAL DIAGNOSTIC LABORATORIES
13.5.1 IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH
13.2 ACADEMIC & RESEARCH INSTITUTES
13.2.1 FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH
13.3 CROS & CDMOS
13.3.1 GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH
13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.4.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION
13.5 CLINICAL DIAGNOSTIC LABORATORIES
13.5.1 IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH
14 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER
14.1 INTRODUCTION
14.2 ACADEMIC & RESEARCH INSTITUTES
14.2.1 NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH
14.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN
14.4 OTHER END USERS
14.2 ACADEMIC & RESEARCH INSTITUTES
14.2.1 NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH
14.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN
14.4 OTHER END USERS
15 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION
15.1 INTRODUCTION
15.2 NORTH AMERICA
15.2.1 US
15.2.1.1 US to dominate North American spatial genomics & transcriptomics market during forecast period
15.2.2 CANADA
15.2.2.1 Favorable government initiatives and high incidence of infectious diseases to support market growth
15.3 EUROPE
15.3.1 GERMANY
15.3.1.1 Advanced genomics research and presence of several key companies to spur market growth
15.3.2 UK
15.3.2.1 Increasing government funding and rising demand for new diagnostic biomarkers to aid market growth
15.3.3 FRANCE
15.3.3.1 Increasing investments in life science R&D and rising number of biotech companies to propel market growth
15.3.4 ITALY
15.3.4.1 Increasing focus on disease research and expanding diagnostic capabilities to augment market growth
15.3.5 SPAIN
15.3.5.1 Focus on advanced cancer research and increased need for personalized medicines to propel market growth
15.3.6 REST OF EUROPE
15.4 ASIA PACIFIC
15.4.1 CHINA
15.4.1.1 Advancing domestic spatial technologies and AI-enabled data analysis are strengthening spatial biology research
15.4.2 JAPAN
15.4.2.1 Strategic acquisitions and integrated spatial workflows are accelerating technology adoption
15.4.3 INDIA
15.4.3.1 Expanding genomics research and precision oncology are creating opportunities for spatial analysis technologies
15.4.4 SOUTH KOREA
15.4.4.1 Biotechnology investment and research access programs are supporting spatial transcriptomics adoption
15.4.5 AUSTRALIA
15.4.5.1 Research infrastructure and industry partnerships are expanding access to spatial omics technologies
15.4.6 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 BRAZIL
15.5.1.1 National genomics initiatives and precision public health are creating pathways for spatial transcriptomics adoption
15.5.2 MEXICO
15.5.2.1 Strengthening genomic research infrastructure and computational expertise is supporting spatial biology opportunities
15.5.3 REST OF LATIN AMERICA
15.6 MIDDLE EAST
15.7 AFRICA
15.2 NORTH AMERICA
15.2.1 US
15.2.1.1 US to dominate North American spatial genomics & transcriptomics market during forecast period
15.2.2 CANADA
15.2.2.1 Favorable government initiatives and high incidence of infectious diseases to support market growth
15.3 EUROPE
15.3.1 GERMANY
15.3.1.1 Advanced genomics research and presence of several key companies to spur market growth
15.3.2 UK
15.3.2.1 Increasing government funding and rising demand for new diagnostic biomarkers to aid market growth
15.3.3 FRANCE
15.3.3.1 Increasing investments in life science R&D and rising number of biotech companies to propel market growth
15.3.4 ITALY
15.3.4.1 Increasing focus on disease research and expanding diagnostic capabilities to augment market growth
15.3.5 SPAIN
15.3.5.1 Focus on advanced cancer research and increased need for personalized medicines to propel market growth
15.3.6 REST OF EUROPE
15.4 ASIA PACIFIC
15.4.1 CHINA
15.4.1.1 Advancing domestic spatial technologies and AI-enabled data analysis are strengthening spatial biology research
15.4.2 JAPAN
15.4.2.1 Strategic acquisitions and integrated spatial workflows are accelerating technology adoption
15.4.3 INDIA
15.4.3.1 Expanding genomics research and precision oncology are creating opportunities for spatial analysis technologies
15.4.4 SOUTH KOREA
15.4.4.1 Biotechnology investment and research access programs are supporting spatial transcriptomics adoption
15.4.5 AUSTRALIA
15.4.5.1 Research infrastructure and industry partnerships are expanding access to spatial omics technologies
15.4.6 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 BRAZIL
15.5.1.1 National genomics initiatives and precision public health are creating pathways for spatial transcriptomics adoption
15.5.2 MEXICO
15.5.2.1 Strengthening genomic research infrastructure and computational expertise is supporting spatial biology opportunities
15.5.3 REST OF LATIN AMERICA
15.6 MIDDLE EAST
15.7 AFRICA
16 COMPETITIVE LANDSCAPE
16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2023-SEPTEMBER 2026
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS,JANUARY 2023-SEPTEMBER 2026
16.3 REVENUE ANALYSIS, 2021-2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.5.1 STARS
16.5.2 EMERGING LEADERS
16.5.3 PERVASIVE PLAYERS
16.5.4 PARTICIPANTS
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.5.5.1 Company footprint
16.5.5.2 Region footprint
16.5.5.3 Offering footprint
16.5.5.4 Technique footprint
16.5.5.5 Application footprint
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.6.1 PROGRESSIVE COMPANIES
16.6.2 RESPONSIVE COMPANIES
16.6.3 DYNAMIC COMPANIES
16.6.4 STARTING BLOCKS
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.6.5.1 Detailed list of key startup/SME players
16.6.5.2 Competitive benchmarking of startups/SMEs
16.7 COMPANY VALUATION AND FINANCIAL METRICS
16.7.1 COMPANY VALUATION
16.7.2 COMPANY VALUATION
16.8 BRAND COMPARISON
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES
16.9.2 DEALS
16.9.3 EXPANSIONS
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2023-SEPTEMBER 2026
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS,JANUARY 2023-SEPTEMBER 2026
16.3 REVENUE ANALYSIS, 2021-2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.5.1 STARS
16.5.2 EMERGING LEADERS
16.5.3 PERVASIVE PLAYERS
16.5.4 PARTICIPANTS
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.5.5.1 Company footprint
16.5.5.2 Region footprint
16.5.5.3 Offering footprint
16.5.5.4 Technique footprint
16.5.5.5 Application footprint
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.6.1 PROGRESSIVE COMPANIES
16.6.2 RESPONSIVE COMPANIES
16.6.3 DYNAMIC COMPANIES
16.6.4 STARTING BLOCKS
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.6.5.1 Detailed list of key startup/SME players
16.6.5.2 Competitive benchmarking of startups/SMEs
16.7 COMPANY VALUATION AND FINANCIAL METRICS
16.7.1 COMPANY VALUATION
16.7.2 COMPANY VALUATION
16.8 BRAND COMPARISON
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES
16.9.2 DEALS
16.9.3 EXPANSIONS
17 COMPANY PROFILES
17.1 KEY PLAYERS
17.1.1 10X GENOMICS
17.1.1.1 Business overview
17.1.1.2 Products/Services/Solutions offered
17.1.1.3 Recent developments
17.1.1.3.1 Product/Service launches
17.1.1.3.2 Deals
17.1.1.3.3 Expansions
17.1.1.4 Analyst's view
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 BIO-TECHNE
17.1.2.1 Business overview
17.1.2.2 Products/Services/Solutions offered
17.1.2.3 Recent developments
17.1.2.3.1 Product/Service launches
17.1.2.3.2 Deals
17.1.2.4 Analyst's view
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 BRUKER
17.1.3.1 Business overview
17.1.3.2 Products/Services/Solutions offered
17.1.3.3 Recent developments
17.1.3.3.1 Deals
17.1.3.4 Analyst's view
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 STANDARD BIOTOOLS INC.
17.1.4.1 Business overview
17.1.4.2 Products/Services/Solutions offered
17.1.4.3 Recent developments
17.1.4.3.1 Product launches
17.1.4.3.2 Deals
17.1.4.4 Analyst's view
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses and competitive threats
17.1.5 ILLUMINA, INC.
17.1.5.1 Business overview
17.1.5.2 Products/Services/Solutions offered
17.1.5.3 Recent developments
17.1.5.3.1 Product launches
17.1.5.3.2 Deals
17.1.5.4 Analyst's view
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses and competitive threats
17.1.6 BIO-RAD LABORATORIES, INC.
17.1.6.1 Business overview
17.1.6.2 Products/Services/Solutions offered
17.1.6.3 Recent developments
17.1.6.3.1 Product launches
17.1.6.3.2 Deals
17.1.6.4 Analyst's view
17.1.6.4.1 Key strengths
17.1.6.4.2 Strategic choices
17.1.6.4.3 Weaknesses and competitive threats
17.1.7 VISIOPHARM A/S
17.1.7.1 Business overview
17.1.7.2 Products/Services/Solutions offered
17.1.7.3 Recent developments
17.1.7.3.1 Product launches
17.1.8 DANAHER CORPORATION
17.1.8.1 Business overview
17.1.8.2 Products/Services/Solutions offered
17.1.8.3 Recent developments
17.1.8.3.1 Deals
17.1.9 VELSERA INC.
17.1.9.1 Business overview
17.1.9.2 Products/Services/Solutions offered
17.1.10 REVVITY, INC.
17.1.10.1 Business overview
17.1.10.2 Products/Services/Solutions offered
17.1.10.3 Recent developments
17.1.10.3.1 Deals
17.1.11 VIZGEN, INC.
17.1.11.1 Business overview
17.1.11.2 Products/Services/Solutions offered
17.1.11.3 Recent developments
17.1.11.3.1 Product launches
17.1.11.3.2 Deals
17.1.12 TAKARA HOLDINGS INC.
17.1.12.1 Business overview
17.1.12.2 Products/Services/Solutions offered
17.1.12.3 Recent developments
17.1.12.3.1 Deals
17.1.12.3.2 Expansions
17.1.13 BGI GENOMICS CO., LTD.
17.1.13.1 Business overview
17.1.13.2 Products/Services/Solutions offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.1.14 MACROGEN, INC.
17.1.14.1 Business overview
17.1.14.2 Products/Services/Solutions offered
17.1.14.3 Recent developments
17.1.14.3.1 Deals
17.1.14.3.2 Expansions
17.1.15 MILTENYI BIOTEC
17.1.15.1 Business overview
17.1.15.2 Products/Services/Solutions offered
17.1.15.3 Recent developments
17.1.15.3.1 Deals
17.2 OTHER PLAYERS
17.2.1 BIOMARKER TECHNOLOGIES (BMKGENE)
17.2.2 PRECISION CELL SYSTEMS, INC.
17.2.3 ADMERA HEALTH
17.2.4 SONY BIOTECHNOLOGY INC.
17.2.5 CANTATA BIO
17.2.6 NUCLEAI, INC.
17.2.7 COMPLETE GENOMICS INCORPORATED
17.2.8 BIOSPYDER, INC.
17.2.9 SINGULAR GENOMICS SYSTEMS, INC.
17.2.10 REBUS BIOSYSTEMS, INC.
17.2.11 SPATIAL GENOMICS
17.1.1 10X GENOMICS
17.1.1.1 Business overview
17.1.1.2 Products/Services/Solutions offered
17.1.1.3 Recent developments
17.1.1.3.1 Product/Service launches
17.1.1.3.2 Deals
17.1.1.3.3 Expansions
17.1.1.4 Analyst's view
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 BIO-TECHNE
17.1.2.1 Business overview
17.1.2.2 Products/Services/Solutions offered
17.1.2.3 Recent developments
17.1.2.3.1 Product/Service launches
17.1.2.3.2 Deals
17.1.2.4 Analyst's view
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 BRUKER
17.1.3.1 Business overview
17.1.3.2 Products/Services/Solutions offered
17.1.3.3 Recent developments
17.1.3.3.1 Deals
17.1.3.4 Analyst's view
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 STANDARD BIOTOOLS INC.
17.1.4.1 Business overview
17.1.4.2 Products/Services/Solutions offered
17.1.4.3 Recent developments
17.1.4.3.1 Product launches
17.1.4.3.2 Deals
17.1.4.4 Analyst's view
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses and competitive threats
17.1.5 ILLUMINA, INC.
17.1.5.1 Business overview
17.1.5.2 Products/Services/Solutions offered
17.1.5.3 Recent developments
17.1.5.3.1 Product launches
17.1.5.3.2 Deals
17.1.5.4 Analyst's view
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses and competitive threats
17.1.6 BIO-RAD LABORATORIES, INC.
17.1.6.1 Business overview
17.1.6.2 Products/Services/Solutions offered
17.1.6.3 Recent developments
17.1.6.3.1 Product launches
17.1.6.3.2 Deals
17.1.6.4 Analyst's view
17.1.6.4.1 Key strengths
17.1.6.4.2 Strategic choices
17.1.6.4.3 Weaknesses and competitive threats
17.1.7 VISIOPHARM A/S
17.1.7.1 Business overview
17.1.7.2 Products/Services/Solutions offered
17.1.7.3 Recent developments
17.1.7.3.1 Product launches
17.1.8 DANAHER CORPORATION
17.1.8.1 Business overview
17.1.8.2 Products/Services/Solutions offered
17.1.8.3 Recent developments
17.1.8.3.1 Deals
17.1.9 VELSERA INC.
17.1.9.1 Business overview
17.1.9.2 Products/Services/Solutions offered
17.1.10 REVVITY, INC.
17.1.10.1 Business overview
17.1.10.2 Products/Services/Solutions offered
17.1.10.3 Recent developments
17.1.10.3.1 Deals
17.1.11 VIZGEN, INC.
17.1.11.1 Business overview
17.1.11.2 Products/Services/Solutions offered
17.1.11.3 Recent developments
17.1.11.3.1 Product launches
17.1.11.3.2 Deals
17.1.12 TAKARA HOLDINGS INC.
17.1.12.1 Business overview
17.1.12.2 Products/Services/Solutions offered
17.1.12.3 Recent developments
17.1.12.3.1 Deals
17.1.12.3.2 Expansions
17.1.13 BGI GENOMICS CO., LTD.
17.1.13.1 Business overview
17.1.13.2 Products/Services/Solutions offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.1.14 MACROGEN, INC.
17.1.14.1 Business overview
17.1.14.2 Products/Services/Solutions offered
17.1.14.3 Recent developments
17.1.14.3.1 Deals
17.1.14.3.2 Expansions
17.1.15 MILTENYI BIOTEC
17.1.15.1 Business overview
17.1.15.2 Products/Services/Solutions offered
17.1.15.3 Recent developments
17.1.15.3.1 Deals
17.2 OTHER PLAYERS
17.2.1 BIOMARKER TECHNOLOGIES (BMKGENE)
17.2.2 PRECISION CELL SYSTEMS, INC.
17.2.3 ADMERA HEALTH
17.2.4 SONY BIOTECHNOLOGY INC.
17.2.5 CANTATA BIO
17.2.6 NUCLEAI, INC.
17.2.7 COMPLETE GENOMICS INCORPORATED
17.2.8 BIOSPYDER, INC.
17.2.9 SINGULAR GENOMICS SYSTEMS, INC.
17.2.10 REBUS BIOSYSTEMS, INC.
17.2.11 SPATIAL GENOMICS
18 RESEARCH METHODOLOGY
18.1 RESEARCH DATA
18.1.1 SECONDARY DATA
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY DATA
18.1.2.1 Key data from primary sources
18.1.2.2 Key primary participants
18.1.2.3 Breakdown of primary interviews
18.1.2.4 Key industry insights
18.2 MARKET SIZE ESTIMATION
18.2.1 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
18.2.2 SEGMENTAL MARKET SIZE ESTIMATION
18.3 MARKET GROWTH RATE PROJECTIONS
18.4 DATA TRIANGULATION
18.5 FACTOR ANALYSIS
18.6 RESEARCH ASSUMPTIONS
18.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT
18.1.1 SECONDARY DATA
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY DATA
18.1.2.1 Key data from primary sources
18.1.2.2 Key primary participants
18.1.2.3 Breakdown of primary interviews
18.1.2.4 Key industry insights
18.2 MARKET SIZE ESTIMATION
18.2.1 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
18.2.2 SEGMENTAL MARKET SIZE ESTIMATION
18.3 MARKET GROWTH RATE PROJECTIONS
18.4 DATA TRIANGULATION
18.5 FACTOR ANALYSIS
18.6 RESEARCH ASSUMPTIONS
18.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT
19 APPENDIX
19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
19.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSISOF MARKET DYNAMICS
TABLE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,2023-2025 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,2023-2025 (USD)
TABLE 7 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION,2023-2025 (USD)
TABLE 8 IMPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY,2021-2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY,2021-2025 (USD THOUSAND)
TABLE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
TABLE 13 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025
TABLE 14 LIST OF KEY PATENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023-2025
TABLE 15 CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
TABLE 16 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INDUSTRY STANDARDS,BY COUNTRY
TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
TABLE 23 KEY BUYING CRITERIA, BY END USER (PRODUCT)
TABLE 24 KEY BUYING CRITERIA, BY END USER (SERVICES)
TABLE 25 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 29 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 31 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2023-2031 (USD MILLION)
TABLE 33 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 34 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 36 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2023-2031(UNITS)
TABLE 38 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023-2031 (USD MILLION)
TABLE 39 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 40 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 42 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 43 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 44 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 45 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 46 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 47 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 48 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 49 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 50 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 51 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 52 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 53 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 54 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 55 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2023-2031 (USD MILLION)
TABLE 56 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 57 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 58 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 59 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 60 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY REGION, 2023-2031 (USD MILLION)
TABLE 61 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 62 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 63 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 64 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 65 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 66 IN SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 67 NORTH AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 68 EUROPE: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 69 ASIA PACIFIC: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 70 LATIN AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 71 SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 72 NORTH AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 73 EUROPE: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 74 ASIA PACIFIC: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 75 LATIN AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 76 OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 77 NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 78 EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 79 ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 80 LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 81 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION,BY REGION, 2023-2031 (USD MILLION)
TABLE 82 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 83 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 84 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 85 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 86 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2023-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 88 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 90 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 91 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2023-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 93 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 94 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 95 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 96 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023-2031 (USD MILLION)
TABLE 97 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 98 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 99 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 100 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 101 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2023-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 103 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 105 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 106 SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 107 SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 109 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 111 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 112 SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2023-2031 (USD MILLION)
TABLE 113 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 114 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 115 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 116 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 117 SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023-2031 (USD MILLION)
TABLE 118 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 119 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 120 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 121 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 122 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 123 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY REGION, 2023-2031 (USD MILLION)
TABLE 124 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 125 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 126 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 127 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 128 MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 129 NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 130 EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 132 LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 133 CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 134 NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 135 EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 136 ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 137 LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 138 OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 139 NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 140 EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 141 ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 142 LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 143 SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY REGION, 2023-2031 (USD MILLION)
TABLE 144 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 145 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 146 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 147 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 148 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 149 SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 150 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 151 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 153 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 154 SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 155 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 156 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 157 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 158 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 159 SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 160 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 161 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 162 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 163 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 164 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 165 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 166 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2023-2031 (USD MILLION)
TABLE 167 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 168 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 169 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 170 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 171 TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY REGION,2023-2031 (USD MILLION)
TABLE 172 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 173 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 174 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 175 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 176 TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY REGION,2023-2031 (USD MILLION)
TABLE 177 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 178 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 179 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 180 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 181 TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY REGION,2023-2031 (USD MILLION)
TABLE 182 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 183 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 184 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 185 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 186 TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2031 (USD MILLION)
TABLE 187 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 188 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 189 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 190 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 191 TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY REGION,2023-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 193 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 194 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 195 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 196 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 198 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 199 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 200 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 201 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 202 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2031 (USD MILLION)
TABLE 203 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 204 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 205 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 206 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 207 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023-2031 (USD MILLION)
TABLE 208 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 209 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 211 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 212 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,2023-2031 (USD MILLION)
TABLE 213 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 214 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 216 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 217 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2023-2031 (USD MILLION)
TABLE 218 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 219 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 221 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 222 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 223 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2031 (USD MILLION)
TABLE 224 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 225 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 226 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 227 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 228 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,2023-2031 (USD MILLION)
TABLE 229 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 230 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 231 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 232 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 233 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHEREND USERS, BY REGION, 2023-2031 (USD MILLION)
TABLE 234 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 235 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 237 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 238 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 239 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 240 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 241 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 242 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 243 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 244 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 245 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 246 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 247 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 248 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 249 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 250 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 251 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 252 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 253 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 254 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 255 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 256 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 257 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 258 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 259 US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 260 US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 261 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 262 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 263 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 264 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 265 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 266 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 267 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 268 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 269 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 270 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 271 CANADA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 272 CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 273 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 274 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 275 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 276 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 277 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 278 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 279 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 280 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 281 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 282 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 283 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 284 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 285 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 286 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 287 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 288 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 289 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 290 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 291 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 292 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 293 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 294 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 295 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 296 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 297 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 298 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 299 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 300 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 301 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 302 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 303 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 304 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 305 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 306 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 307 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 308 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 309 UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 310 UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 311 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 312 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 313 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 314 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 315 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 316 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 317 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 318 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 319 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 320 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 321 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 322 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 323 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 324 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 325 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 326 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 327 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 328 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 329 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 330 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 331 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 332 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 333 ITALY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 334 ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 335 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 336 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 337 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 338 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 339 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 340 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 341 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 342 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 343 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 344 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 345 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 346 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 347 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 348 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 349 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 350 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 351 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 352 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 353 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 354 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 355 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 356 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 357 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 358 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 359 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 360 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 361 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 362 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 363 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 364 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 365 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 366 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 367 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 368 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 369 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 370 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 371 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 372 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 373 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 374 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 375 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 376 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 377 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 378 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 379 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 380 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 381 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 382 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 383 CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 384 CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 385 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 386 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 387 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 388 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 389 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 390 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 391 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 392 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 393 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 394 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 395 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 396 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 397 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 398 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 399 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 400 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 401 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 402 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 403 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 404 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 405 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 406 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 407 INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 408 INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 409 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 410 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 411 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 412 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 413 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 414 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 415 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 416 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 417 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 418 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 419 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 420 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 421 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 422 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 423 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 424 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 425 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 426 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 427 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 428 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 429 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 430 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 431 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 432 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 433 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 434 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 435 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 436 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 437 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 447 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 448 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 449 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 450 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 451 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 452 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 453 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 454 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 455 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 456 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 457 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 458 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 459 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 460 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 461 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 462 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 463 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 464 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 465 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 466 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 467 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 468 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 469 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 470 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 471 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 472 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 473 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 474 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 475 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 476 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 477 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 478 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 479 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 480 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 481 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 482 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 483 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 484 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 485 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 486 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 487 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 488 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 489 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 490 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 491 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 492 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 493 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 494 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 495 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 496 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 497 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 498 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 499 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 500 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 501 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 502 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 503 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 504 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 505 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 506 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 507 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 508 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 509 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 510 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 511 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 512 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 513 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 514 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 515 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 516 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 517 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 518 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 519 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 520 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 521 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 522 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 523 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 524 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2023-SEPTEMBER 2026
TABLE 525 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEGREE OF COMPETITION
TABLE 526 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT
TABLE 527 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT
TABLE 528 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT
TABLE 529 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT
TABLE 530 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 531 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 532 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 533 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS,JANUARY 2023-SEPTEMBER 2026
TABLE 534 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: EXPANSIONS,JANUARY 2023-SEPTEMBER 2026
TABLE 535 10X GENOMICS: COMPANY OVERVIEW
TABLE 536 10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 537 10X GENOMICS: PRODUCT/SERVICE LAUNCHES,JANUARY 2023-SEPTEMBER 2026
TABLE 538 10X GENOMICS: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 539 10X GENOMICS: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 540 BIO-TECHNE: COMPANY OVERVIEW
TABLE 541 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 542 BIO-TECHNE: PRODUCT/SERVICE LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 543 BIO-TECHNE: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 544 BRUKER: COMPANY OVERVIEW
TABLE 545 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 546 BRUKER: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 547 STANDARD BIOTOOLS INC.: COMPANY OVERVIEW
TABLE 548 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 549 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 550 STANDARD BIOTOOLS INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 551 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 552 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 553 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 554 ILLUMINA, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 555 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 556 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 557 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,JANUARY 2023-SEPTEMBER 2026
TABLE 558 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 559 VISIOPHARM A/S: COMPANY OVERVIEW
TABLE 560 VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 561 VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 562 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 563 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 564 DANAHER CORPORATION: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 565 VELSERA INC.: COMPANY OVERVIEW
TABLE 566 VELSERA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 567 REVVITY, INC.: COMPANY OVERVIEW
TABLE 568 REVVITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 569 REVVITY, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 570 VIZGEN, INC.: COMPANY OVERVIEW
TABLE 571 VIZGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 572 VIZGEN, INC.: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 573 VIZGEN, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 574 TAKARA HOLDINGS INC.: COMPANY OVERVIEW
TABLE 575 TAKARA HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 576 TAKARA HOLDINGS INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 577 TAKARA HOLDINGS INC.: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 578 BGI GENOMICS CO., LTD.: COMPANY OVERVIEW
TABLE 579 BGI: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 580 BGI: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 581 MACROGEN, INC.: COMPANY OVERVIEW
TABLE 582 MACROGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 583 MACROGEN, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 584 MACROGEN, INC.: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 585 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 586 MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 587 MILTENYI BIOTEC: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 588 BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW
TABLE 589 PRECISION CELL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 590 ADMERA HEALTH: COMPANY OVERVIEW
TABLE 591 SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW
TABLE 592 CANTATA BIO: COMPANY OVERVIEW
TABLE 593 NUCLEAI, INC.: COMPANY OVERVIEW
TABLE 594 COMPLETE GENOMICS INCORPORATED: COMPANY OVERVIEW
TABLE 595 BIOSPYDER, INC.: COMPANY OVERVIEW
TABLE 596 SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 597 REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 598 SPATIAL GENOMICS: COMPANY OVERVIEW
TABLE 599 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 600 RISK ASSESSMENT
TABLE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSISOF MARKET DYNAMICS
TABLE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,2023-2025 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,2023-2025 (USD)
TABLE 7 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION,2023-2025 (USD)
TABLE 8 IMPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY,2021-2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 9027-COMPLIANT PRODUCTS, BY COUNTRY,2021-2025 (USD THOUSAND)
TABLE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
TABLE 13 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025
TABLE 14 LIST OF KEY PATENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023-2025
TABLE 15 CASE STUDIES OF AI IMPLEMENTATION IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
TABLE 16 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SPATIAL GENOMICS & TRANSCRIPTOMICS TECHNOLOGIES IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INDUSTRY STANDARDS,BY COUNTRY
TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
TABLE 23 KEY BUYING CRITERIA, BY END USER (PRODUCT)
TABLE 24 KEY BUYING CRITERIA, BY END USER (SERVICES)
TABLE 25 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 29 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 31 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2023-2031 (USD MILLION)
TABLE 33 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 34 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 36 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2023-2031(UNITS)
TABLE 38 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023-2031 (USD MILLION)
TABLE 39 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 40 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 42 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 43 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 44 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 45 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 46 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 47 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 48 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 49 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 50 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 51 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 52 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 53 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 54 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 55 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2023-2031 (USD MILLION)
TABLE 56 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 57 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 58 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 59 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 60 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY REGION, 2023-2031 (USD MILLION)
TABLE 61 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 62 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 63 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 64 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 65 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 66 IN SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 67 NORTH AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 68 EUROPE: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 69 ASIA PACIFIC: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 70 LATIN AMERICA: IN SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 71 SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 72 NORTH AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 73 EUROPE: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 74 ASIA PACIFIC: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 75 LATIN AMERICA: SINGLE-CELL RNA SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 76 OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 77 NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 78 EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 79 ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 80 LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 81 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION,BY REGION, 2023-2031 (USD MILLION)
TABLE 82 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 83 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 84 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 85 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 86 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2023-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 88 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 90 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 91 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2023-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 93 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 94 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 95 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 96 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023-2031 (USD MILLION)
TABLE 97 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 98 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 99 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 100 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 101 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2023-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 103 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 105 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 106 SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 107 SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 109 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 111 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 112 SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2023-2031 (USD MILLION)
TABLE 113 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 114 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 115 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 116 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 117 SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2023-2031 (USD MILLION)
TABLE 118 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 119 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 120 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 121 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 122 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 123 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY REGION, 2023-2031 (USD MILLION)
TABLE 124 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 125 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 126 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 127 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 128 MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 129 NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 130 EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 132 LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 133 CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 134 NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 135 EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 136 ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 137 LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 138 OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 139 NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 140 EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 141 ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 142 LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 143 SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY REGION, 2023-2031 (USD MILLION)
TABLE 144 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 145 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 146 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 147 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMICS TECHNIQUES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 148 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 149 SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 150 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 151 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 153 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 154 SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 155 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 156 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 157 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 158 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 159 SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 160 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 161 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 162 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 163 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 164 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 165 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 166 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2023-2031 (USD MILLION)
TABLE 167 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 168 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 169 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 170 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 171 TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY REGION,2023-2031 (USD MILLION)
TABLE 172 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 173 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 174 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 175 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 176 TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY REGION,2023-2031 (USD MILLION)
TABLE 177 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 178 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 179 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 180 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 181 TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY REGION,2023-2031 (USD MILLION)
TABLE 182 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 183 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 184 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 185 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 186 TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2031 (USD MILLION)
TABLE 187 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 188 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 189 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 190 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 191 TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY REGION,2023-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 193 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 194 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 195 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 196 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 198 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 199 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 200 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 201 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 202 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2031 (USD MILLION)
TABLE 203 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 204 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 205 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 206 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 207 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023-2031 (USD MILLION)
TABLE 208 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 209 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 211 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 212 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,2023-2031 (USD MILLION)
TABLE 213 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 214 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 216 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 217 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2023-2031 (USD MILLION)
TABLE 218 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 219 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 221 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 222 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 223 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2031 (USD MILLION)
TABLE 224 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 225 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 226 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 227 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 228 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,2023-2031 (USD MILLION)
TABLE 229 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 230 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 231 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 232 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,2023-2031 (USD MILLION)
TABLE 233 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHEREND USERS, BY REGION, 2023-2031 (USD MILLION)
TABLE 234 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 235 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 237 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 238 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2023-2031 (USD MILLION)
TABLE 239 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION,2023-2031 (USD MILLION)
TABLE 240 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 241 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 242 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 243 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 244 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 245 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 246 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 247 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 248 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 249 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 250 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 251 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 252 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 253 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 254 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 255 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 256 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 257 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 258 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 259 US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 260 US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 261 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 262 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 263 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 264 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 265 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 266 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 267 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 268 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 269 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 270 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 271 CANADA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 272 CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 273 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 274 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 275 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 276 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 277 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 278 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 279 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 280 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 281 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 282 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 283 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 284 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 285 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 286 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 287 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 288 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 289 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 290 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 291 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 292 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 293 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 294 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 295 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 296 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 297 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 298 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 299 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 300 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 301 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 302 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 303 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 304 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 305 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 306 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 307 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 308 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 309 UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 310 UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 311 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 312 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION,2023-2031 (USD MILLION)
TABLE 313 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 314 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 315 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 316 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 317 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 318 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 319 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 320 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 321 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 322 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 323 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 324 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 325 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 326 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 327 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 328 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 329 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 330 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 331 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 332 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 333 ITALY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 334 ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 335 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 336 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 337 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 338 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 339 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 340 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 341 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 342 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 343 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 344 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 345 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 346 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 347 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 348 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 349 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 350 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 351 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 352 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 353 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 354 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 355 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 356 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 357 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 358 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 359 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 360 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 361 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 362 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 363 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 364 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 365 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 366 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 367 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 368 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 369 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 370 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 371 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 372 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 373 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 374 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 375 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 376 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 377 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 378 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 379 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 380 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 381 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 382 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 383 CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 384 CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 385 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 386 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 387 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 388 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 389 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 390 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 391 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 392 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 393 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 394 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 395 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 396 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 397 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 398 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 399 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 400 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 401 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 402 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 403 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 404 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 405 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 406 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 407 INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 408 INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 409 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 410 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 411 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 412 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 413 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 414 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 415 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 416 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 417 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 418 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 419 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 420 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 421 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 422 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 423 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 424 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 425 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 426 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 427 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 428 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 429 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 430 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 431 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 432 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 433 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 434 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 435 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 436 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 437 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 443 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 444 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 445 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 446 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 447 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 448 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 449 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 450 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 451 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY COUNTRY, 2023-2031 (USD MILLION)
TABLE 452 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 453 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 454 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 455 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 456 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 457 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 458 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 459 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 460 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 461 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 462 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 463 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 464 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 465 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 466 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 467 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 468 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 469 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 470 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 471 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 472 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 473 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 474 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 475 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 476 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 477 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 478 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 479 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 480 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 481 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 482 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 483 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 484 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 485 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 486 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 487 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 488 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY OFFERING, 2023-2031 (USD MILLION)
TABLE 489 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 490 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 491 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 492 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 493 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 494 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 495 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 496 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 497 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 498 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 499 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2023-2031 (USD MILLION)
TABLE 500 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2023-2031 (USD MILLION)
TABLE 501 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 502 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 503 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 504 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 505 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 506 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 507 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 508 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET,BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 509 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 510 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 511 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 512 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING,2023-2031 (USD MILLION)
TABLE 513 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TYPE, 2023-2031 (USD MILLION)
TABLE 514 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY TECHNIQUE, 2023-2031 (USD MILLION)
TABLE 515 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 516 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2023-2031 (USD MILLION)
TABLE 517 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE,2023-2031 (USD MILLION)
TABLE 518 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING,BY TYPE, 2023-2031 (USD MILLION)
TABLE 519 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2023-2031 (USD MILLION)
TABLE 520 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2023-2031 (USD MILLION)
TABLE 521 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2023-2031 (USD MILLION)
TABLE 522 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 523 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET,BY END USER, 2023-2031 (USD MILLION)
TABLE 524 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2023-SEPTEMBER 2026
TABLE 525 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEGREE OF COMPETITION
TABLE 526 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT
TABLE 527 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT
TABLE 528 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT
TABLE 529 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT
TABLE 530 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 531 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 532 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 533 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS,JANUARY 2023-SEPTEMBER 2026
TABLE 534 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: EXPANSIONS,JANUARY 2023-SEPTEMBER 2026
TABLE 535 10X GENOMICS: COMPANY OVERVIEW
TABLE 536 10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 537 10X GENOMICS: PRODUCT/SERVICE LAUNCHES,JANUARY 2023-SEPTEMBER 2026
TABLE 538 10X GENOMICS: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 539 10X GENOMICS: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 540 BIO-TECHNE: COMPANY OVERVIEW
TABLE 541 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 542 BIO-TECHNE: PRODUCT/SERVICE LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 543 BIO-TECHNE: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 544 BRUKER: COMPANY OVERVIEW
TABLE 545 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 546 BRUKER: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 547 STANDARD BIOTOOLS INC.: COMPANY OVERVIEW
TABLE 548 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 549 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 550 STANDARD BIOTOOLS INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 551 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 552 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 553 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 554 ILLUMINA, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 555 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 556 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 557 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,JANUARY 2023-SEPTEMBER 2026
TABLE 558 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 559 VISIOPHARM A/S: COMPANY OVERVIEW
TABLE 560 VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 561 VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 562 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 563 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 564 DANAHER CORPORATION: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 565 VELSERA INC.: COMPANY OVERVIEW
TABLE 566 VELSERA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 567 REVVITY, INC.: COMPANY OVERVIEW
TABLE 568 REVVITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 569 REVVITY, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 570 VIZGEN, INC.: COMPANY OVERVIEW
TABLE 571 VIZGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 572 VIZGEN, INC.: PRODUCT LAUNCHES, JANUARY 2023-SEPTEMBER 2026
TABLE 573 VIZGEN, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 574 TAKARA HOLDINGS INC.: COMPANY OVERVIEW
TABLE 575 TAKARA HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 576 TAKARA HOLDINGS INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 577 TAKARA HOLDINGS INC.: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 578 BGI GENOMICS CO., LTD.: COMPANY OVERVIEW
TABLE 579 BGI: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 580 BGI: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 581 MACROGEN, INC.: COMPANY OVERVIEW
TABLE 582 MACROGEN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 583 MACROGEN, INC.: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 584 MACROGEN, INC.: EXPANSIONS, JANUARY 2023-SEPTEMBER 2026
TABLE 585 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 586 MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 587 MILTENYI BIOTEC: DEALS, JANUARY 2023-SEPTEMBER 2026
TABLE 588 BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW
TABLE 589 PRECISION CELL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 590 ADMERA HEALTH: COMPANY OVERVIEW
TABLE 591 SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW
TABLE 592 CANTATA BIO: COMPANY OVERVIEW
TABLE 593 NUCLEAI, INC.: COMPANY OVERVIEW
TABLE 594 COMPLETE GENOMICS INCORPORATED: COMPANY OVERVIEW
TABLE 595 BIOSPYDER, INC.: COMPANY OVERVIEW
TABLE 596 SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 597 REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 598 SPATIAL GENOMICS: COMPANY OVERVIEW
TABLE 599 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 600 RISK ASSESSMENT
LIST OF FIGURES
FIGURE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION
FIGURE 2 REGIONS CONSIDERED
FIGURE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED
FIGURE 4 MARKET SCENARIO
FIGURE 5 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2024-2031
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023-2026
FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
FIGURE 8 HIGH-GROWTH SEGMENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2026-2031
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10 HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
FIGURE 11 PRODUCTS ACCOUNTED FOR LARGEST SHARE OF THE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET IN NORTH AMERICA IN 2025
FIGURE 12 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET TILL 2031
FIGURE 13 TRANSLATIONAL RESEARCH TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 14 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 VALUE CHAIN ANALYSIS
FIGURE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
FIGURE 20 AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD)
FIGURE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023-2025 (USD MILLION)
FIGURE 23 PATENT APPLICATIONS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2015-DECEMBER 2025
FIGURE 24 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 26 KEY BUYING CRITERIA, BY END USER (PRODUCT)
FIGURE 27 KEY BUYING CRITERIA, BY END USER (SERVICES)
FIGURE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021-2025 (USD MILLION)
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT
FIGURE 34 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36 EV/EBITDA OF KEY VENDORS
FIGURE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND COMPARISON
FIGURE 38 10X GENOMICS: COMPANY SNAPSHOT
FIGURE 39 BIO-TECHNE: COMPANY SNAPSHOT
FIGURE 40 BRUKER: COMPANY SNAPSHOT
FIGURE 41 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
FIGURE 42 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 45 REVVITY, INC.: COMPANY SNAPSHOT
FIGURE 46 TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
FIGURE 47 BGI GENOMICS CO., LTD.: COMPANY SNAPSHOT
FIGURE 48 MACROGEN, INC.: COMPANY SNAPSHOT
FIGURE 49 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN
FIGURE 50 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BREAKDOWN OF PRIMARIES
FIGURE 51 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INSIGHTS FROM PRIMARIES
FIGURE 52 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
FIGURE 53 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
FIGURE 54 ILLUSTRATIVE EXAMPLE OF BIO-TECHNE: REVENUE ANALYSIS (2025)
FIGURE 55 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 56 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS
FIGURE 57 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DATA TRIANGULATION
FIGURE 2 REGIONS CONSIDERED
FIGURE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED
FIGURE 4 MARKET SCENARIO
FIGURE 5 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2024-2031
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2023-2026
FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
FIGURE 8 HIGH-GROWTH SEGMENTS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2026-2031
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10 HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
FIGURE 11 PRODUCTS ACCOUNTED FOR LARGEST SHARE OF THE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET IN NORTH AMERICA IN 2025
FIGURE 12 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET TILL 2031
FIGURE 13 TRANSLATIONAL RESEARCH TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 14 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 VALUE CHAIN ANALYSIS
FIGURE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
FIGURE 20 AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD)
FIGURE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023-2025 (USD MILLION)
FIGURE 23 PATENT APPLICATIONS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, JANUARY 2015-DECEMBER 2025
FIGURE 24 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 26 KEY BUYING CRITERIA, BY END USER (PRODUCT)
FIGURE 27 KEY BUYING CRITERIA, BY END USER (SERVICES)
FIGURE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021-2025 (USD MILLION)
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT
FIGURE 34 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36 EV/EBITDA OF KEY VENDORS
FIGURE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND COMPARISON
FIGURE 38 10X GENOMICS: COMPANY SNAPSHOT
FIGURE 39 BIO-TECHNE: COMPANY SNAPSHOT
FIGURE 40 BRUKER: COMPANY SNAPSHOT
FIGURE 41 STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
FIGURE 42 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 45 REVVITY, INC.: COMPANY SNAPSHOT
FIGURE 46 TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
FIGURE 47 BGI GENOMICS CO., LTD.: COMPANY SNAPSHOT
FIGURE 48 MACROGEN, INC.: COMPANY SNAPSHOT
FIGURE 49 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN
FIGURE 50 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BREAKDOWN OF PRIMARIES
FIGURE 51 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INSIGHTS FROM PRIMARIES
FIGURE 52 GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET ESTIMATION, 2025
FIGURE 53 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
FIGURE 54 ILLUSTRATIVE EXAMPLE OF BIO-TECHNE: REVENUE ANALYSIS (2025)
FIGURE 55 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 56 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS
FIGURE 57 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DATA TRIANGULATION

